Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure-Reference-Cited by-同舟云学术

Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure

Published:2013-11-14 Issue:7 Volume:170 Page:1396-1409
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Gong Wei¹,Duan Quanlu¹,Cai Zhejun¹,Chen Chen¹,Ni Li¹,Yan Mengwen¹,Wang Xingxu¹,Cianflone Katherine²,Wang Dao Wen¹

Affiliation:

1. Department of Internal Medicine and Gene Therapy Center; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Wuhan China

2. Centre de Recherche; Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval; Québec QC Canada

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12346/fullpdf

Reference36 articles.

1. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association;Cheitlin;J Am Coll Cardiol,1999

2. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta;Das;J Biol Chem,2008

3. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure;Davies;Circulation,1995

4. A new 15-50 MHz array-based micro-ultrasound scanner for preclinical imaging;Foster;Ultrasound Med Biol,2009

5. Postnatal trends in creatinemia and its covariates in extremely low birth weight (ELBW) neonates;George;Pediatr Nephrol,2011a

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoplasmic reticulum stress-mediated cell death in cardiovascular disease;Cell Stress and Chaperones;2024-02

2. Pde5 Inhibition Reduced Blood Pressure and Alleviated Target Organ Damage in Chronic Intermittent Hypoxia;Journal of Cardiovascular Pharmacology;2023-11-23

3. Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents;Pharmaceuticals;2023-10-12

4. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24

5. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24